Thomas L. Avery

983 total citations
41 papers, 775 citations indexed

About

Thomas L. Avery is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Thomas L. Avery has authored 41 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 10 papers in Public Health, Environmental and Occupational Health and 7 papers in Infectious Diseases. Recurrent topics in Thomas L. Avery's work include Biochemical and Molecular Research (11 papers), Acute Lymphoblastic Leukemia research (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Thomas L. Avery is often cited by papers focused on Biochemical and Molecular Research (11 papers), Acute Lymphoblastic Leukemia research (10 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Thomas L. Avery collaborates with scholars based in United States, Myanmar and Ireland. Thomas L. Avery's co-authors include Gaston K. Rivera, DeWayne Roberts, Roland K. Robins, Raymond L. Blakley, Rick A. Finch, Gary V. Dahl, E.F. Graham, Rhomes J. A. Aur, Adynel Wood and Yoon S. Cho‐Chung and has published in prestigious journals such as Science, Cancer and Cancer Research.

In The Last Decade

Thomas L. Avery

39 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas L. Avery United States 16 339 200 183 159 139 41 775
G.A. Fischer United States 12 795 2.3× 198 1.0× 140 0.8× 111 0.7× 109 0.8× 17 1.1k
John P. Durham United States 17 876 2.6× 63 0.3× 130 0.7× 58 0.4× 76 0.5× 41 1.1k
Louise F. Momparler Canada 21 1.1k 3.1× 109 0.5× 153 0.8× 56 0.4× 338 2.4× 36 1.3k
Larry W. Brox Canada 21 865 2.6× 118 0.6× 173 0.9× 50 0.3× 113 0.8× 42 1.2k
V.Sagar Sethi United States 17 530 1.6× 47 0.2× 249 1.4× 95 0.6× 32 0.2× 44 936
Bruce J. Dolnick United States 22 944 2.8× 73 0.4× 337 1.8× 53 0.3× 54 0.4× 46 1.2k
Peter Hilgard Germany 15 286 0.8× 227 1.1× 125 0.7× 96 0.6× 78 0.6× 32 747
Natalia F. Krynetskaia United States 18 630 1.9× 486 2.4× 227 1.2× 35 0.2× 83 0.6× 28 1.3k
T. Klenner Germany 12 205 0.6× 189 0.9× 201 1.1× 210 1.3× 55 0.4× 25 706
Michael J. Absalon United States 14 941 2.8× 73 0.4× 427 2.3× 84 0.5× 172 1.2× 34 1.3k

Countries citing papers authored by Thomas L. Avery

Since Specialization
Citations

This map shows the geographic impact of Thomas L. Avery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas L. Avery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas L. Avery more than expected).

Fields of papers citing papers by Thomas L. Avery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas L. Avery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas L. Avery. The network helps show where Thomas L. Avery may publish in the future.

Co-authorship network of co-authors of Thomas L. Avery

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas L. Avery. A scholar is included among the top collaborators of Thomas L. Avery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas L. Avery. Thomas L. Avery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanyal, Shyamal K., et al.. (2015). Management of Severe Respiratory Insufficiency Due to Pneumocystis carinii Pneumonitis in Immunosuppressed Hosts. American Review of Respiratory Disease.
2.
3.
Parandoosh, Zahra, Boanerges Rubalcava, Rick A. Finch, R. K. ROBINS, & Thomas L. Avery. (1990). Changes in diacylglycerol and membrane associated protein kinase C activity reflect the growth status of xenografted human mammary carcinoma treated with 8-Cl-cAMP. Cancer Letters. 49(3). 195–200. 5 indexed citations
4.
5.
6.
Ally, Shamsia, Timothy Clair, Dionyssios Katsaros, et al.. (1990). Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cyclic adenosine monophosphate. Lung Cancer. 6(3-4). 124–125. 68 indexed citations
7.
Ojo-Amaize, Emmanuel A., Boanerges Rubalcava, Thomas L. Avery, et al.. (1990). Activation of the respiratory burst in murine phagocytes by certain guanine ribonucleosides modified at the 7 and 8 positions: possible involvement of a pertussis toxin-sensitive G-protein. Immunology Letters. 23(3). 173–178. 12 indexed citations
8.
Kini, Ganesh D., Roland K. Robins, & Thomas L. Avery. (1989). Synthesis and antitumor activity of ribavirin imidates. New facile synthesis of ribavirin amidine (1-.beta.-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride). Journal of Medicinal Chemistry. 32(7). 1447–1449. 19 indexed citations
9.
Nord, L. Dee, Randall C. Willis, Thomas L. Avery, et al.. (1989). Inhibition of phosphoribosylpyrophosphate synthetase by 4-methoxy-(MRPP) and 4-amino-8-(d-ribofuranosylamino)pyrimido[5,4-d]pyrimidine (ARPP). Biochemical Pharmacology. 38(20). 3543–3549. 7 indexed citations
10.
Sanghvi, Yogesh S., Steven B. Larson, Steven S. Matsumoto, et al.. (1989). Antitumor and antiviral activity of synthetic .alpha.- and .beta.-ribonucleosides of certain substituted pyrimido[5,4-d]pyrimidines: a new synthetic strategy for exocyclic aminonucleosides. Journal of Medicinal Chemistry. 32(3). 629–637. 58 indexed citations
11.
Cho‐Chung, Yoon S., Timothy Clair, P Tagliaferri, et al.. (1989). Site-Selective Cyclic AMP Analogs as New Biological Tools in Growth Control, Differentiation, and Proto-oncogene Regulation. Cancer Investigation. 7(2). 161–177. 72 indexed citations
12.
Avery, Thomas L., et al.. (1989). Biochemical pharmacology of 2-chlorodeoxyadenosine in malignant human hematopoietic cell lines and therapeutic effects of 2-bromodeoxyadenosine in drug combinations in mice.. PubMed. 49(18). 4972–8. 64 indexed citations
13.
Nemec, J.F., Rick A. Finch, & Thomas L. Avery. (1985). Epipodophyllotoxinquinone glucoside derivatives - New etoposide and teniposide analogues. Proceedings of the American Association for Cancer Research. 26. 1 indexed citations
14.
Rivera, Gaston K., Gary V. Dahl, W. Paul Bowman, et al.. (1980). VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia. Cancer. 46(8). 1727–1730. 45 indexed citations
15.
Avery, Thomas L., et al.. (1978). Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(9). 2892–5. 3 indexed citations
16.
Avery, Thomas L. & DeWayne Roberts. (1974). Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210. European Journal of Cancer (1965). 10(7). 425–429. 19 indexed citations
17.
Avery, Thomas L. & E.F. Graham. (1962). INVESTIGATIONS ASSOCIATED WITH THE TRANSPLANTATION OF BOVINE OVA. Reproduction. 3(2). 218–228. 6 indexed citations
18.
Avery, Thomas L., et al.. (1962). INVESTIGATIONS ASSOCIATED WITH THE TRANSPLANTATION OF BOVINE OVA. Reproduction. 3(2). 206–211. 18 indexed citations
19.
Avery, Thomas L., M. L. FAHNING, V. G. Pursel, & E.F. Graham. (1962). INVESTIGATIONS ASSOCIATED WITH THE TRANSPLANTATION OF BOVINE OVA. Reproduction. 3(2). 229–238. 11 indexed citations
20.
Avery, Thomas L., M. L. FAHNING, & E.F. Graham. (1962). INVESTIGATIONS ASSOCIATED WITH THE TRANSPLANTATION OF BOVINE OVA. Reproduction. 3(2). 212–217. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G.A. Fischer Breakdown of academic impact, for papers by John P. Durham Breakdown of academic impact, for papers by Louise F. Momparler Breakdown of academic impact, for papers by Larry W. Brox Breakdown of academic impact, for papers by V.Sagar Sethi Breakdown of academic impact, for papers by Bruce J. Dolnick Breakdown of academic impact, for papers by Peter Hilgard Breakdown of academic impact, for papers by Natalia F. Krynetskaia Breakdown of academic impact, for papers by T. Klenner Breakdown of academic impact, for papers by Michael J. Absalon
Rankless by CCL
2026